Silence Therapeutics PLC Sponsored ADR
(NASDAQ: SLN)
Silence Therapeutics Plc engages in the discovery, delivery, and development of ribonucleic acid (RNA) therapeutics. It also develops medicines by harnessing the body's natural mechanism of RNA interference within its cells. The company was founded on November 18, 1994 and is headquartered in London, the United Kingdom.
7.130
+0.800
(+12.64%)
Range
6.190 - 7.160
(15.67%)
Open
6.280
Previous Close
6.330
Bid Price
5.970
Bid Volume
14
Ask Price
6.020
Ask Volume
9
Volume
656,865
Value
-
Remark
Delayed prices. Updated at 05 Dec 2025 05:00.
Data powered by
View All Events
Loading Chart...
Please login to view stock data and analysis
